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Abstract 
Japanese encephalitis virus (JEV) replicates
in a variety of cells, the exact intracellular site
of virus assembly is somewhat obscure. The
aims of this study were to investigate the role
Golgi apparatus in JEV maturation by utilizing
two Golgi-disrupting agents- brefeldin A (BFA)
and monensin (MN) that inhibit virus assem-
bly  at  specific  cellular  sites.  JEV-infected
porcine kidney stable (PS) cells were treated
with BFA (2 ug/ mL) or MN (10 uM/ mL) at dif-
ferent  h  post-infection  (p.  i.)  and  the  virus
contents were assayed after 48 h p. i. The treat-
ed cells were further subjected to immuno-flu-
orescence  (IF)  using  antibodies  directed
against  JEV  envelope  glycoprotein  (gpE)  for
localization  of  intracellular  viral  antigen  as
well as the antigen expression on the cell sur-
face. Addition of BFA or MN to cells immediate-
ly after virus adsorption or at 4 h and 12 h post-
infection (p. i.), resulted in 4- or 8- fold reduc-
tion  in  infectious  virus  contents  along  with
inhibition of its transport to the cell surface,
indicating an essential role of the Golgi-associ-
ated  membranes  in  JEV  replication.
Interestingly, the antigenicity of the virus, in
contrast, remained unaffected as no difference
in  epitope  presentation/  expression  was
observed  in  BFA/MN-treated  and  control
(untreated) infected cells even though in the
former cells a loss of hemagglutinating (HA)
activity was observed. Further, BFA addition at
18 h or 24 h p. i. showed only a negligible effect
on virus suggesting that once the viral-associ-
ated  membranes  are  formed,  these  mem-
branes  appear  to  be  stable.  In  contrast,  the
inhibition  with  MN  persisted  even  after  its
addition to cells at 18 h and 24 h p. i., indicat-
ing its sustained effect on JEV. Although BFA
inhibits  protein  transport  from  endoplasmic
reticulum (ER) to the Golgi complex while MN
inhibits transport from medial to trans cister-
nae  of  the  Golgi  complex,  none  of  the  two
agents however affected the gpE synthesis and
folding  essentially  required  for  the  epitope
presentation/expression  within  the  cells.  As
flaviviruses are known to encode three glyco-
proteins (gps) within their genomes i. e., prM,
E, and NS, it will be worthwhile in future to
determine whether vesicular transport occurs
within  or  between  the  virus-induced  mem-
branes  and  how  the  individual  JEV-encoded
proteins are transported to discrete compart-
ments further remain to be seen. 
Introduction
Japanese encephalitis virus (JEV) is one of
the most dreaded mosquito-borne flaviviruses
(the  genus-  Flavivirus and  family-
Flaviviridae) that causes frequent epidemics
of  acute  encephalitis  throughout  South-east
Asia and Western Pacific regions.1-3 The dis-
ease has also emerged in the non-Asian region
such  as  Northern  Australia  as  reported  in
recent past.4The virus replicates in a variety of
cells- of mammalian, avian and mosquito ori-
gin  and  is  probably  released  by  a  budding
process.5 Using  Kunjin  virus  (KUNV)  as  a
model to study the events of flavivirus replica-
tion, it appears that virus particles are closely
associated  with  the  KUN  factories  in  which
compartmentalization  within  the  induced
membranes occurs to ensure efficient replica-
tion; the exact intracellular site of flavivirus
assembly somewhat remains obscure.6,7 Ultra-
structural  studies  of  flavivirus-infected  cells
have  consistently  revealed  apparent  mature
virions within distended endoplasmic reticu-
lum (ER), large cytoplasmic vesicles, and vac-
uoles.8 In addition, occasional sections have
shown individual particles within Golgi cister-
nae,  indicating  that  flavivirus  maturation
might be proceeding through the Golgi appara-
tus.9,10However, this process may not be a gen-
eralized phenomenon for all the flaviviruses as
the viral E protein which is the binding site of
neutralizing  antibodies,  is  glycosylated  in
some flaviviruses while in others it is unglyco-
sylated.6,11 The JEV gpE has one conserved N-
glycosylation site at the amino acid 150 from
the  N-terminus.12-14 The  glycans  associated
with the JEV gpE are converted in to complex
forms prior to the virus release from cells and
in the presence of tunicamycin (Tm), a potent
N-glycosylation inhibitor, the secretion of gpE
is significantly impaired while that of NS 1 and
NS  1’  is  completely  abolished.15 In  contrast,
Brefeldin A (BFA) is a fungal metabolite that
disrupts intracellular membrane traffic at the
ER-Golgi junction while monensin (MN) is a
well-characterized metabolite of Streptomyces
cinnamonensis that  binds  Na+,  K+ and  pro-
teins, and inhibits trans-Golgi function by pre-
venting the protein transport from medial to
trans-cisternae of Golgi compartment.16,17Both
BFA  and  MN  have  effectively  been  used  to
inhibit the transport and secretion of a number
of  cellular  and  viral  proteins  in  a  variety  of
cells.6,7 Our  preliminary  studies  with  JEV
revealed that treatment of PS cells with BFA
added  immediately  after  virus  adsorption
resulted in inhibition of virus maturation and
its transport to the cell surface.18 The present
study was undertaken utilizing both BFA and
MN  in  order  to  attempt  inhibition  of  virus
assembly at specific cellular sites in PS cells
and assessing their effect by determining the
virus yield along with localization of intracellu-
lar viral antigen as well as the antigen expres-
sion  on  the  cell  surface  using  antibodies
directed against JEV gpE by immuno-fluores-
cence (IF). 
Materials and Methods 
Virus and cells
The details of JEV and PS cells used during
the study are given elsewhere.18,19 In brief, JEV
strain 733913, originally isolated from a fatal
case of JE was adapted to PS cells grown in
Earle's  based  minimum  essential  medium
(MEM, Gibco, invitrogen Corp., Carlsbad, CA,
USA) supplemented with 10% of goat serum.
The virus passaging in PS cells was carried out
in MEM supplemented with 2% goat serum and
the virus stocks were stored at -70°C. 
Monoclonal and polyclonal antibodies
Monoclonal antibodies (MAbs) were raised
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earlier in our laboratory against JEV gpE and
were grouped as HAI- positive, HAI- negative
virus- specific, HAI- positive, HAI- negative fla-
vivirus cross-reactive and HAI- negative auto-
reactive  MAbs  depending  on  their  reactivity
with JEV, West Nile and Dengue viruses.20,21
The respective hybrid cells were maintained in
the Dulbecco's based MEM supplemented with
10%  fetal  calf  serum  (both  from  Gibco)  and
were  inoculated  intra-peritoneally  into  pris-
tane-primed BALB/c mice, ascitic fluids (AFs)
were collected by standard methods. Control AF
was also obtained by inoculating SP2/0 cells or
a  MAb  prepared  against  Chikungunya  virus
(CHIKV-an  Alphavirus,  the  family-
Togaviridiae)  which  did  not  cross-react  with
JEV,  served  as  negative  control.22 Polyclonal
antibodies (PAbs) to JEV and a control AF were
raised in Swiss mice by immunization with JEV
or  control  (uninfected)  antigen  respectively,
followed  by  ascites  production  employing
Ehrlich's tumor cells by standard procedures. 
Japanese encephalitis virus infec-
tion and Brefeldin A/Monensin
treatment of PS cells
Confluent  PS  monolayers  grown  in  2.5''
petri  dishes  and  on  coverslips  in  Leighton
tubes  were  infected  with  JEV  as  mentioned
elsewhere.18,19 After virus adsorption at 37°C
for 1 hr, the virus inoculum was removed and
MEM supplemented with 2% goat serum and
BFA (2 ug/ mL) or MN (10 uM/ mL) (both from
Sigma-Aldrich Corp., St. Louis, MO, USA) was
added. The cells grown on medium but without
BFA or MN served as controls. The cells were
incubated for various times at 37°C prior to
assaying  the  infectious  virus  and  for  anti-
genicity by IF. 
Immunofluorescence studies
Coverslips with virus-infected cell monolay-
ers either treated or untreated with BFA/ MN
were fixed at 24 h and 48 h post-infection (p.
i.)  in  chilled  acetone  (-20°C)  for  20  min,
probed with different MAbs or JEV antiserum
diluted  1:100  and  stained  with  a  goat  anti-
mouse  immunoglobulin  fluorescein  isothio-
cyanate (GAM Ig-FITC) conjugate (Sigma).23
The  cells  were  also  probed  for  surface
immunofluorescence (IF) at 36 h p.i. by treat-
ing the unfixed cells with different MAbs or
JEV antiserum diluted 1:100 in MEM contain-
ing  sodium  azide  as  mentioned  earlier.24
Subsequently, the antibody-treated cells were
fixed in chilled acetone (-20°C) for 20 min and
stained  with  a  GAM  Ig-FITC  conjugate  as
above. 
Assaying of infectious virus
Tissue culture supernates (TCFs) and cell
lysates collected from the treated cells and the
untreated  (control)  cells  at  48  h  p.  i.  were
assayed for the infectious virus in vitro (by
plaque titration in PS cells using 24-well plate)
as  described  earlier.18,19 The  results  were
expressed as log PFU/mL. 
Hemagglutination assay
The  effect  of  BFA  and  MN  on
Hemagglutination  (HA)  activity  of  the  virus
was studied by assaying HA titres of the TCFs
and cell lysates collected from both treated and
untreated virus-infected cells employing goose
erythrocytes as described earlier.19
Treatment of Japanese encephalitis
virus -infected PS cells with
Brefeldin/Monensin for different
times
BFA  and  MN  were  similarly  added  to  the
infected cells at various times viz. 4, 12, 18 and
24 h p. i. rather than immediately after virus
adsorption. In some experiments, BFA and MN
were  added  immediately  after  virus  adsorp-
tion; these were removed from the treated cells
at various times viz. 4, 12, 18 and 24 h p. i. and
the cells were incubated further without BFA
or MN. TCFs and cell lysates collected from the
cells were assayed at 48 h p. i. for the infec-
tious virus as above. 
Results 
Incubation of JEV-infected cells in presence
of BFA or MN added immediately after virus
adsorption drastically reduced the intracellular
and extracellular infectious virus yield at 48 h
p.  i.  by  about  4-fold  and  8-fold,  respectively
(Figure 1). This was further accompanied with
undetectable HA activity of the virus with the
treated  cells  (HA  titres  of  1:48  to  96  with
untreated cells yielding 7.5-8.0 logs of the virus
as against 1.0-2.0 logs only with the treated
cells). Whereas, the intracellular presentation
of the epitopes on JEV gpE however, appeared
to be unaffected either by the BFA or MN treat-
ment of infected cells which showed character-
istic apple- green IF at 24 h and 48 h p. i. with
the  MAbs  and  PAbs  to  JEV.  In  contrast,  the
MAbs and PAbs failed to produce any IF on the
surface of BFA/ MN treated cells at 36 h. p. i.,
indicating  a  defective  virus  transport  and/or
virus assembly as reported earlier with BFA.18
No IF with SP2/0 or CHIKV MAb and control AF
was seen with treated or untreated infected
cells by either method. 
Further,  BFA  or  MN  addition  to  the  cells
even at 4 h or 12 h p. i. resulted in a drastical-
ly reduced infectious virus yield (Figure 2). In
contrast, the inhibitory effect of BFA was neg-
ligible at 18 h or 24 h p. i. as only a marginal
decrease in virus yield was recorded in com-
parison to the MN. Even removal of MN (at 4,
12, 18 and 24 h p. i.) after its addition to the
cells immediately after virus adsorption pro-
duced only a little change, indicating a sus-
tained effect produced by MN in comparison to
BFA  (Figure  3).  As  the  characteristic  virus-
induced  membranes  are  not  clearly  formed
until about the end of the latent period i. e.
about 12 h-15 h, the present results with BFA
therefore, indicate an essential involvement of
some of the Golgi apparatus-associated mem-
branes in JEV replication.6,7 Once these viral-
associated membranes are formed as observed
on BFA addition just after the end of latent
period i. e., 18 h and later on, the previously
induced  membranes  appear  to  be  stable/
resistant. In contrast, the inhibition with MN
Article
Figure  1.  Virus  infec-
tivity  titres  in  TCFs
and cell lysates collect-
ed  at  48  h  p.  i.  from
BFA  or  MN  –  treated
and untreated infected
PS cells. BFA tr. = BFA
treated, MN tr. = MN
treated.
Figure  2.  Addition  of
BFA / MN at different
time  hours  p.i.  Effect
of  BFA  (2  µg/mL)  or
MN (10 µM) added at
different  time  interval
on  JEV  replication  in
PS cells. BFA tr. = BFA
treated, MN tr. = MN
treated.
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persisted even after the end of latent period,
suggesting its sustained effect on JEV. 
Discussion
Flaviviruses  contain  an  electron  dense
icosahedral  nucleocapsid  core  which  is  sur-
rounded by a lipid bilayer containing envelope
protein and the genomic RNA serves itself as
mRNA that gets translated into a long polypro-
tein encoding three structural proteins (C, M
and E) and seven NS proteins.25 The polypro-
tein is processed, co- and post-translationally
into individual proteins by the host and viral
proteases.25-27 The M protein represents C’ ter-
minal cleavage product of the precursor pro-
tein i. e., prM undergoes delayed cleavage that
is taking place just prior to or even during viri-
ons’ release from cells.28-31 The cleavage has
shown to be catalyzed by the host protease-
furin located specifically in trans cisternae of
the Golgi complex.32 As the prM and not M pro-
tein  which  is  glycosylated  and  is  associated
with E protein in a hetero-dimeric form name-
ly, prM-E.33 This interaction between prM and
E protein, namely hetero-dimeric prMis neces-
sary to protect E protein from irreversible con-
formational changes during maturation in the
acidic vesicles of the exocytic pathway.29,31Also
the prM facilitates correct folding of E protein
or alternatively masks a retention signal with-
in it, thus allowing its exit from the ER.34-37
Conclusions
In the present study utilizing the metabolic
inhibitors  that  inhibit  protein  and/or  mem-
brane traffic throughout the cell, the secretion
of JEV particles late in infection was signifi-
cantly  affected/  impaired  in  the  BFA  or  MN
presence along with undetectable antigen on
the cell surface. Thus, it seems that though the
virus yield is affected, BFA or MN treatment
does not affect JEV gpE and its folding essen-
tially required for the epitope expression/ pres-
entation as the inhibition of terminal N-glyco-
sylation, i. e. no addition of sialic acid due to
non-availablity  of  sialyl  transferasee  and  its
location  in  trans-Golgi-network.38,39 As  BFA
treatment of cells restricts anterograde protein
transport between the ER and Golgi apparatus
leading to recycling of viral proteins between
the ER and IC, the present results therefore
suggest the movement of cellular or viral pro-
teins from the ER to the Golgi apparatus that
might essentially be required for membrane
induction,  rather  than  just  accumulation  of
viral proteins within the ER and IC.40 In con-
trast, the movement of virus particles within
the medial Golgi compartment during the MN
treatment may not be arrested but subsequent
furin cleavage of prM was either not occurring
or was very inefficient, thus not allowing the
conformational  change  in  the  E  protein  (of
immature  particles  containing  prM)  that  is
essentially required for un-coating and fusion
with endosomal membranes after infection.15
In addition to the obvious inhibition of cleav-
age of prM, MN also appears in some unknown
way to inhibit the cleavage.29 Therefore, it will
be worthwhile in future to determine whether
vesicular transport occurs within or between
the  virus-induced  membranes  and  how  the
individual JEV-encoded proteins are transport-
ed to discrete compartments further remains
to be seen.
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